Last reviewed · How we verify
Extrapyramidal disease
Approved treatments
- Artane
- Cogentin · University of Southern California
- Artane
- Kemadrine
- Akineton · AbbVie
- Gocovri · Endo
- Cogentin
- GOCOVRI · Oregon Health and Science University
- Amantadin · Centre Hospitalier Universitaire de Nice
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Extrapyramidal disease patent landscape — cliff calendar, originator estates, attackable patents
- Extrapyramidal disease treatment landscape brief
- Extrapyramidal disease treatment updates RSS
Frequently asked questions about Extrapyramidal disease
What drugs treat Extrapyramidal disease?
Tracked treatments include Artane, Cogentin, Kemadrine, Akineton, Gocovri, GOCOVRI, Amantadin.
What is the treatment for Extrapyramidal disease?
Standard treatment for Extrapyramidal disease includes Artane, Cogentin, Kemadrine, Akineton, Gocovri. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Extrapyramidal disease patent cliff · Extrapyramidal disease CI report
- Treatment: Artane
- Treatment: Cogentin · University of Southern California
- Treatment: Artane
- Treatment: Kemadrine
- Treatment: Akineton · AbbVie
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing